Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, July the 26th 2016, 07:00-10:00

ZORA's new graphical user interface will be relaunched (For further infos watch out slideshow ZORA: Neues Look & Feel). There will be short interrupts on ZORA Service between 07:00am and 10:00 am. Please be patient.

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-63178

Dummer, R; Beyer, M; Hymes, K; Epping, M T; Bernards, R; Steinhoff, M; Sterry, W; Kerl, H; Heath, K; Ahern, J D; Hardwick, J S; Garcia-Vargas, J; Baumann, K; Rizvi, S; Frankel, S R; Whittacker, S J; Assaf, C (2012). Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition. Leukemia and Lymphoma, 53(8):1501-1508.

[img]Published Version
PDF - Registered users only
View at publisher


The retinoid X receptor (RXR)-agonist bexarotene and the histone deacetylase inhibitor (HDACI) vorinostat are each established monotherapies for cutaneous T-cell lymphomas (CTCLs). We investigated the combination of HDACI and retinoic acid receptor (RAR)/RXR agonists in vitro and in a phase I, multicenter, open-label, two-part dose-escalation study. The combination of bexarotene with a HDACI in vitro leads to cooperative activation of gene transcription and reduction of cell viability in human tumor cell lines. The primary clinical objective was to determine the maximum tolerated dose (MTD) of bexarotene plus vorinostat in 23 patients with CTCLs. The MTD for part I was established at vorinostat 200 mg/day plus bexarotene 300 mg/m 2 /day. The
MTD for part II was not reached. Four patients had an active response and seven patients experienced pruritus relief. We conclude that concomitant administration of vorinostat and bexarotene is feasible only if lower doses of each drug are administered relative to the product label monotherapy doses.


18 citations in Web of Science®
20 citations in Scopus®
Google Scholar™



1 download since deposited on 09 Jul 2012
0 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Date:8 January 2012
Deposited On:09 Jul 2012 09:00
Last Modified:05 Apr 2016 15:52
Publisher:Informa Healthcare
Publisher DOI:10.3109/10428194.2012.656625
PubMed ID:22239668

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page